These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11221281)

  • 1. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
    Mandema JW; Cox E; Alderman J
    Cephalalgia; 2005 Sep; 25(9):715-25. PubMed ID: 16109054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eletriptan.
    Sandrini G; Perrotta A; Tassorelli C; Nappi G
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
    Al-Shekhlee A; Reed R
    Neurology; 2000 Sep; 55(5):735-6. PubMed ID: 11041768
    [No Abstract]   [Full Text] [Related]  

  • 10. Eletriptan in migraine.
    Diener HC
    Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials.
    Sakai F; Diener HC; Ryan R; Poole P
    Curr Med Res Opin; 2004 Mar; 20(3):269-77. PubMed ID: 15025836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study.
    Sandrini G; Färkkilä M; Burgess G; Forster E; Haughie S;
    Neurology; 2002 Oct; 59(8):1210-7. PubMed ID: 12391349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.
    Färkkilä M; Olesen J; Dahlöf C; Stovner LJ; ter Bruggen JP; Rasmussen S; Muirhead N; Sikes C
    Cephalalgia; 2003 Jul; 23(6):463-71. PubMed ID: 12807526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies].
    Pascual J; Leira R; Lainez JM; Liaño H; Díez-Tejedor E; Navarro A; Jiménez D; Ezpeleta D; Mateos V; Madrigal M; Palacios G;
    Neurologia; 2004 Oct; 19(8):414-9. PubMed ID: 15470580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
    Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS
    Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eletriptan.
    Gawel MJ; Grujich NN
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.